STOCK TITAN

iAnthus Announces Resignation of Director

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

iAnthus Capital Holdings announced the resignation of board member Zachary Arrick, effective February 21, 2023. Arrick joined the board on June 24, 2022, following the company's recapitalization. Interim CEO Robert Galvin expressed gratitude for Arrick's contributions. According to the Investor Rights Agreement from June 24, 2022, the investor who nominated Arrick may designate a successor; however, no replacement has been appointed yet. iAnthus operates regulated cannabis operations across the U.S.

Positive
  • Potential for fresh leadership perspectives with the nomination of a successor.
Negative
  • Uncertainty following the resignation with no current board replacement.
  • Possible continuity issues in strategic decision-making.

NEW YORK and TORONTO, Feb. 22, 2023 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces that Zachary Arrick has resigned from the board of directors of the Company (the "Board"), effective February 21, 2023. Mr. Arrick joined the Board on June 24, 2022 upon completion of the Company's previously announced recapitalization transaction.

"On behalf of the entire iAnthus team, we thank Zach for the valuable contributions and strategic insights he brought to the Board after closing the Recapitalization Transaction.  We wish Zach the best in all his future endeavors," said Robert Galvin, iAnthus Interim Chief Executive Officer.

Pursuant to the Investor Rights Agreement dated June 24, 2022 by and among the Company, iAnthus Capital Management, LLC, a wholly-owned subsidiary of the Company, and certain Investors (as defined therein), the Investor who nominated Mr. Arrick is entitled to designate a successor nominee for appointment to the Board, and the Company is required to cause such nominee to be appointed to the Board. As of the date hereof, such Investor has not nominated a successor nominee, and the Company has not appointed a replacement for Mr. Arrick. A copy of the Investor Rights Agreement is available on the Company's SEDAR profile at www.sedar.com and the U.S. Securities and Exchange Commission's ("SEC's") website at www.sec.gov.

About iAnthus

iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States. For more information, visit www.iAnthus.com.

Forward Looking Statements

Statements in this news release contain forward-looking statements. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Company's reports that it files from time to time with the SEC and the Canadian securities regulators which you should review including, but not limited to, the Company's Annual Report on Form 10-K filed with the SEC. When used in this news release, words such as "will," could," plan," estimate," expect," intend," may," potential," believe, "should" and similar expressions, are forward-looking statements. Forward-looking statements may include, without limitation, statements relating to the Company's financial performance, business development and results of operations and the nomination and appointment of a replacement/successor director to the Board.

These forward-looking statements should not be relied upon as predictions of future events, and the Company cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by the Company or any other person that it will achieve its objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this news release or to reflect the occurrence of unanticipated events, except as required by law.

Neither the Canadian Securities Exchange nor the SEC has reviewed, approved or disapproved the content of this news release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ianthus-announces-resignation-of-director-301752979.html

SOURCE iAnthus Capital Holdings, Inc.

FAQ

What is the significance of Zachary Arrick's resignation from iAnthus's board?

Zachary Arrick's resignation may impact the board's strategic direction, as no successor has been appointed yet.

Who will replace Zachary Arrick on iAnthus's board?

The investor who nominated Arrick is entitled to appoint a successor, but as of now, none has been named.

When did Zachary Arrick resign from the iAnthus board?

Zachary Arrick resigned effective February 21, 2023.

How might the board changes affect iAnthus's future?

The lack of a board replacement may create uncertainty in leadership and decision-making processes.

IANTHUS CAPITAL HLDG ORD

OTC:ITHUF

ITHUF Rankings

ITHUF Latest News

ITHUF Stock Data

45.93M
3.75B
5.18%
85.18%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto